Kailera

This study tests a new weekly injection called KAI-9531 in 1700 adults who are overweight or have obesity and type 2 diabetes. The goal is to see if it helps with weight loss and lowering blood sugar better than a placebo. Participants will receive the shot or a dummy injection f…

This study tests a new weekly injection, KAI-9531, to see if it helps people with obesity lose more weight than semaglutide (the drug in Ozempic/Wegovy) or a placebo. About 1,200 adults with a BMI of 35 or higher who have tried and failed to lose weight through diet and exercise …

This study tests a new medicine called KAI-9531, given as a weekly shot, to help people with obesity lose weight. About 250 adults with a BMI of 35 or higher who have tried and failed to lose weight through diet and exercise in the past 6 months will take part. Participants will …

This study tests an experimental daily pill called KAI-7535 to see if it helps people with obesity or overweight lose more weight than a placebo. The trial includes 320 adults who also have at least one weight-related health problem like high blood pressure or sleep apnea. Partic…